Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX)

  • Event
  • July 01, 2022, 20:30 UTC
  • 10
  • 1 comments

(99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Files Form 8-K

Comment Full text

Nektar Therapeutics (NKTR)

  • Event
  • July 01, 2022, 20:15 UTC
  • 10
  • 1 comments

(99% Neutral) NEKTAR THERAPEUTICS (NKTR) Announces New Board Appointment

Comment Full text

Spero Therapeutics Inc (SPRO)

  • Event
  • July 01, 2022, 20:06 UTC
  • 10
  • 1 comments

(99% Neutral) SPERO THERAPEUTICS, INC. (SPRO) Announces Executive Changes

Comment Full text

Genmab (GMAB)

  • Event
  • July 01, 2022, 16:23 UTC
  • 9
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

AstraZeneca (AZN)

  • Event
  • July 01, 2022, 14:00 UTC
  • 11
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

Centessa Pharmaceuticals plc (CNTA)

  • Event
  • July 01, 2022, 12:45 UTC
  • 12
  • 1 comments

(75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Clinical Development Update

Comment Full text

KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH)

  • Event
  • July 01, 2022, 12:32 UTC
  • 12
  • 1 comments

(99% Neutral) KemPharm, Inc. (KMPH) Files Form 8-K

Comment Full text

Evelo Biosciences, Inc. (EVLO)

  • Event
  • July 01, 2022, 10:58 UTC
  • 12
  • 1 comments

(35% Negative) EVELO BIOSCIENCES, INC. (EVLO) Announces Business Combination

Comment Full text

Amarin Corporation Plc (AMRN)

  • Event
  • June 30, 2022, 21:20 UTC
  • 13
  • 1 comments

(99% Neutral) AMARIN CORP PLC\UK (AMRN) Announces Regulatory Update

Comment Full text

Geron Corporation Inc (GERN)

  • Event
  • June 30, 2022, 21:15 UTC
  • 12
  • 1 comments

(70% Positive) GERON CORPORATION (GERN) Reports Q2 2022 Financial Results

Comment Full text
  • Previous
  • 170
  • 171
  • 172
  • 173
  • 174
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2275)
  • SEC News(189642)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124645)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin